Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

HEATHER LYNN MCARTHUR

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1790940385
CMS profile
1126111
Location
DALLAS, TX

General Payments · PY2018–2024

$256,926.07

  • Reported across 245 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$66,321.89

45 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Merck Sharp & Dohme Corporation $30,742.95 15
PFIZER INC. $6,670.00 3
AstraZeneca UK Limited $6,473.25 4
Gilead Sciences, Inc. $6,371.47 4
Stemline Therapeutics Inc. $4,908.64 6
Lilly USA, LLC $2,400.00 1
Acerta Pharma LLC $2,185.80 4
Daiichi Sankyo Inc. $1,847.37 2
Delcath Systems $1,800.00 1
NOVARTIS PHARMACEUTICALS CORPORATION $1,797.41 3
Eli Lilly and Company $800.00 1
BOSTON SCIENTIFIC CORPORATION $325.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $22,946.25 47
PY2019 $23,828.23 38
PY2020 $24,403.45 23
PY2021 $18,445.56 11
PY2022 $27,454.65 24
PY2023 $73,526.04 57
PY2024 $66,321.89 45

Payment records · PY2024 (45)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $130.80 03/07/2024 Food and Beverage Undisputed 01/23/2026 1104545582 CMS
AstraZeneca Pharmaceuticals LP $685.00 05/07/2024 Consulting Fee Undisputed 01/23/2026 1104533098 CMS
AstraZeneca Pharmaceuticals LP $685.00 05/08/2024 Consulting Fee Undisputed 01/23/2026 1105740594 CMS
AstraZeneca Pharmaceuticals LP $685.00 11/20/2024 Consulting Fee Undisputed 01/23/2026 1105523965 CMS
AstraZeneca UK Limited $2,740.00 04/09/2024 Consulting Fee Undisputed 01/23/2026 1093957238 CMS
AstraZeneca UK Limited $1,678.25 04/30/2024 Consulting Fee Undisputed 01/23/2026 1094019163 CMS
AstraZeneca UK Limited $685.00 07/10/2024 Consulting Fee Undisputed 01/23/2026 1094047057 CMS
AstraZeneca UK Limited $1,370.00 09/05/2024 Consulting Fee Undisputed 01/23/2026 1093881851 CMS
Boston Scientific Corporation $325.00 11/01/2024 Consulting Fee Undisputed 01/23/2026 1092605336 CMS
Daiichi Sankyo Inc. $134.87 06/03/2024 Food and Beverage Undisputed 01/23/2026 1089454010 CMS
Daiichi Sankyo Inc. $1,712.50 07/31/2024 Consulting Fee Undisputed 01/23/2026 1089454008 CMS
Delcath Systems $1,800.00 08/30/2024 Consulting Fee Undisputed 01/23/2026 1130859826 CMS
Eli Lilly and Company $800.00 05/30/2024 Consulting Fee Undisputed 01/23/2026 1134980220 CMS
Gilead Sciences, Inc. $115.87 06/01/2024 Food and Beverage Undisputed 01/23/2026 1133832472 CMS
Gilead Sciences, Inc. $5,760.00 06/05/2024 Consulting Fee Undisputed 01/23/2026 1133600125 CMS
Gilead Sciences, Inc. $15.60 06/12/2024 Travel and Lodging Undisputed 01/23/2026 1133870000 CMS
Gilead Sciences, Inc. $480.00 08/19/2024 Consulting Fee Undisputed 01/23/2026 1133600127 CMS
Lilly USA, LLC $2,400.00 07/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1134980222 CMS
Merck Sharp & Dohme LLC $150.00 03/25/2024 Travel and Lodging Undisputed 01/23/2026 1141677107 CMS
Merck Sharp & Dohme LLC $4,270.00 03/25/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1141677109 CMS
Merck Sharp & Dohme LLC $223.97 05/16/2024 Travel and Lodging Undisputed 01/23/2026 1141767425 CMS
Merck Sharp & Dohme LLC $223.97 05/17/2024 Travel and Lodging Undisputed 01/23/2026 1141767419 CMS
Merck Sharp & Dohme LLC $10,077.20 05/17/2024 Travel and Lodging Undisputed 01/23/2026 1141767421 CMS
Merck Sharp & Dohme LLC $192.89 05/17/2024 Travel and Lodging Undisputed 01/23/2026 1141767423 CMS
Merck Sharp & Dohme LLC $32.15 05/17/2024 Food and Beverage Undisputed 01/23/2026 1141892592 CMS
Merck Sharp & Dohme LLC $192.89 05/17/2024 Travel and Lodging Undisputed 01/23/2026 1141892594 CMS
Merck Sharp & Dohme LLC $4,270.00 06/10/2024 Consulting Fee Undisputed 01/23/2026 1141677211 CMS
Merck Sharp & Dohme LLC $104.91 06/19/2024 Travel and Lodging Undisputed 01/23/2026 1141677205 CMS
Merck Sharp & Dohme LLC $2,000.00 10/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1141728146 CMS
Merck Sharp & Dohme LLC $7,551.54 11/22/2024 Travel and Lodging Undisputed 01/23/2026 1141677105 CMS
Merck Sharp & Dohme LLC $1,183.32 11/22/2024 Travel and Lodging Undisputed 01/23/2026 1141677207 CMS
Merck Sharp & Dohme LLC $179.93 11/22/2024 Travel and Lodging Undisputed 01/23/2026 1141677209 CMS
Merck Sharp & Dohme LLC $90.18 11/24/2024 Food and Beverage Undisputed 01/23/2026 1141677203 CMS
Novartis Pharmaceuticals Corporation $120.99 03/06/2024 Food and Beverage Undisputed 01/23/2026 1087025656 CMS
Novartis Pharmaceuticals Corporation $1,600.00 06/02/2024 Consulting Fee Undisputed 01/23/2026 1087025690 CMS
Novartis Pharmaceuticals Corporation $76.42 07/11/2024 Food and Beverage Undisputed 01/23/2026 1087025670 CMS
PFIZER INC. $3,150.00 07/18/2024 Consulting Fee Undisputed 01/23/2026 1131615025 CMS
PFIZER INC. $720.00 11/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131611515 CMS
PFIZER INC. $2,800.00 12/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131615029 CMS
Stemline Therapeutics Inc. $1,950.00 02/02/2024 Consulting Fee Undisputed 01/23/2026 1142960345 CMS
Stemline Therapeutics Inc. $1,950.00 08/09/2024 Consulting Fee Undisputed 01/23/2026 1142960349 CMS
Stemline Therapeutics Inc. $63.20 08/20/2024 Food and Beverage Undisputed 01/23/2026 1142960355 CMS
Stemline Therapeutics Inc. $47.51 08/22/2024 Food and Beverage Undisputed 01/23/2026 1142960357 CMS
Stemline Therapeutics Inc. $780.00 08/30/2024 Consulting Fee Undisputed 01/23/2026 1142960351 CMS
Stemline Therapeutics Inc. $117.93 12/09/2024 Food and Beverage Undisputed 01/23/2026 1142960347 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.